부산대학교 도서관

Pistilli B; Department of Medical Oncology, Gustave Roussy Cancer Center, Villejuif, France.; Jhaveri K; Memorial Sloan Kettering Cancer Center, New York, USA; Weill Cornell Medical College, New York, USA.; Im SA; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea.; Pernas S; Institut Català d'Oncologia, IDIBELL, L'Hospitalet, Barcelona, Spain.; De Laurentiis M; Istituto Nazionale Tumori IRCCS 'Fondazione Pascale', Naples, Italy.; Wang S; Cancer Center of Sun Yat-sen University, Guangzhou, China.; Martínez Jañez N; Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Borges G; Catarina Pesquisa Clínica, Itajaí, Brazil.; Cescon DW; Princess Margaret Cancer Centre/UHN, Toronto, Canada.; Hattori M; Department of Breast Oncology, Aichi Cancer Center, Nagoya, Japan; Aichi Breast Clinic Hirabari, Nagoya, Japan.; Lu YS; National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.; Hamilton E; Sarah Cannon Research Institute, Nashville, USA.; Tsurutani J; Advanced Cancer Translational Research Institute, Showa Medical University, Tokyo, Japan.; Kalinsky K; Winship Cancer Institute at Emory University, Atlanta, USA.; Rubini Liedke PE; Hospital das Clínicas de Porto Alegre (HCPA), Porto Alegre, Brazil; UPCO-Pesquisa Clinica em Oncologia, Porto Alegre, Brazil; Oncoclinicas Porto Alegre, Porto Alegre, Brazil.; Carroll D; Translational Medicine, Late-Stage Development, Oncology Research & Development, AstraZeneca, Cambridge, UK.; Khan S; Clinical Development, Late-Stage Development, Oncology Research and Development, AstraZeneca, Gaithersburg, USA.; Rugo HS; University of California San Francisco Comprehensive Cancer Center, San Francisco, USA.; Xu B; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Bardia A; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, USA; Massachusetts General Hospital Cancer Center, Boston, USA. Electronic address: ABardia@mednet.ucla.edu.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Pascual T; SOLTI Cancer Research Group, Barcelona, Spain; Department of Medical Oncology, Cancer Institute and Blood Disorders, Hospital Clínic de Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Medicine Department, University of Barcelona, Barcelona, Spain.; Villacampa G; SOLTI Cancer Research Group, Barcelona, Spain; Statistics Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Oliveira M; SOLTI Cancer Research Group, Barcelona, Spain; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Escrivá-de-Romaní S; SOLTI Cancer Research Group, Barcelona, Spain; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Pernas S; SOLTI Cancer Research Group, Barcelona, Spain; Institut Catala d'Oncologia-IDIBELL, L'Hospitalet, Barcelona, Spain.; Paré L; SOLTI Cancer Research Group, Barcelona, Spain; Reveal Genomics, Barcelona, Spain.; Adamo B; Department of Medical Oncology, Cancer Institute and Blood Disorders, Hospital Clínic de Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Martínez E; Department of Medical Oncology, Consorcio Hospitalario Provincial de Castellón, Castellón de la Plana, Castellón, Spain.; Cortés J; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain.; Perelló A; Department of Medical Oncology, Hospital Son Espases, Palma, Spain.; Galan M; Department of Medical Oncology, Hospital Son Llàtzer, Palma, Spain.; Melé M; Department of Medical Oncology, Hospital Sant Joan, Reus, Spain.; Villanueva L; SOLTI Cancer Research Group, Barcelona, Spain.; Gonzalez-Rodriguez M; Department of Medical Oncology, Cancer Institute and Blood Disorders, Hospital Clínic de Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Tolosa P; SOLTI Cancer Research Group, Barcelona, Spain; Department of Medical Oncology, 12 de Octubre University Hospital, Madrid, Spain; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; González-Farré B; Department of Pathology, Biomedical Diagnostic Center, Hospital Clinic of Barcelona, Barcelona, Spain.; Galván P; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Canes J; SOLTI Cancer Research Group, Barcelona, Spain.; Nuciforo P; Molecular Oncology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Ferrero-Cafiero JM; SOLTI Cancer Research Group, Barcelona, Spain.; González-Farré X; SOLTI Cancer Research Group, Barcelona, Spain; Institut Oncològic Dr. Rosell, Barcelona, Spain; Hospital General de Catalunya, Sant Cugat del Vallès, Barcelona, Spain; Universitat Internacional de Catalunya, Sant Cugat del Vallès, Barcelona, Spain.; Villagrasa P; SOLTI Cancer Research Group, Barcelona, Spain; Reveal Genomics, Barcelona, Spain.; Prat A; Department of Medical Oncology, Cancer Institute and Blood Disorders, Hospital Clínic de Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Medicine Department, University of Barcelona, Barcelona, Spain; Reveal Genomics, Barcelona, Spain; Institute of Oncology (IOB)-Quirón, Barcelona, Spain. Electronic address: alprat@clinic.cat.; Ciruelos E; SOLTI Cancer Research Group, Barcelona, Spain; Department of Medical Oncology, 12 de Octubre University Hospital, Madrid, Spain; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain; Medical Oncology Department, HM Hospitales, Madrid, Spain. Electronic address: eva.ciruelos@gmail.com.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Musulen, E; Noguera-Castells, A; Villagrasa, P; Canes, J; Pascual, T; Galvan, P; Prat, A; Ciruelos, E; Pernas, S; Esteller, M

Laboratory Investigation
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)

Lynce F; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, USA; Harvard Medical School, Boston, USA. Electronic address: Filipa_Lynce@dfci.harvard.edu.; Martínez-Sáez O; Medical Oncology Department, Hospital Clinic, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Walbaum B; Medical Oncology Department, Hospital Clinic, Barcelona, Spain; Department of Hematology-Oncology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.; Brasó-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Waks AG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, USA; Harvard Medical School, Boston, USA.; Villagrasa P; Reveal Genomics, Barcelona, Spain.; Villacampa Javierre G; Statistics Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.; Sanfeliu E; Pathology Department, Hospital Clinic, Barcelona, Spain.; Galván P; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Paré L; Reveal Genomics, Barcelona, Spain.; Anderson LM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, USA.; Perou CM; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA.; Parker JS; Life Edit Therapeutics, Morrisville, USA.; Vivancos A; Cancer Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona.; DiLullo MK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, USA.; Pernas S; Medical Oncology Department, Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain.; Winer EP; Yale Cancer Center, New Haven, USA.; Overmoyer B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, USA; Harvard Medical School, Boston, USA.; Mittendorf EA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, USA; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, USA.; Bueno-Muiño C; Medical Oncology Department, Hospital Infanta Cristina (Parla), Fundación de Investigación Biomédica H.U. Puerta de Hierro, Majadahonda, Madrid, Spain.; Martín M; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Geicam, Universidad Complutense, Madrid, Spain.; Prat A; Medical Oncology Department, Hospital Clinic, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain; Reveal Genomics, Barcelona, Spain; Institute of Oncology (IOB)-Hospital Quirónsalud, Barcelona, Spain.; Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, USA; Harvard Medical School, Boston, USA.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Angelats L; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain.; Paré L; Reveal Genomics, Barcelona, Spain.; Rubio-Perez C; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain.; Sanfeliu E; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Pathology, Hospital Clinic of Barcelona, Barcelona, Spain.; González A; Department of Pathology, Hospital Clinic of Barcelona, Barcelona, Spain; Immunogenetics and Immunotherapy in Autoinflammatory and Immune Responses, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Seguí E; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain.; Villacampa G; Statistics Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Marín-Aguilera M; Reveal Genomics, Barcelona, Spain.; Pernas S; Institut Catala d'Oncologia, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Institut Català d'Oncologia Medical Oncology, Breast Unit Barcelona, Barcelona, Spain.; Conte B; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain.; Albarrán-Fernández V; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain.; Martínez-Sáez O; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain.; Aguirre Á; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain.; Galván P; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain; Reveal Genomics, Barcelona, Spain.; Fernandez-Martinez A; Department of Genetics, University of North Carolina, Chapel Hill, USA.; Cobo S; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain.; Rey M; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain.; Martínez-Romero A; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain.; Walbaum B; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain.; Schettini F; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain.; Vidal M; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain.; Buckingham W; Reveal Genomics, Barcelona, Spain.; Muñoz M; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain.; Adamo B; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain.; Agrawal Y; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA.; Guedan S; Cellular Immunotherapies for Cancer Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Pascual T; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain; SOLTI Cancer Cooperative Group, Barcelona, Spain.; Agudo J; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, USA; Department of Immunology, Harvard Medical School, Boston, USA; Parker Institute for Cancer Immunotherapy at Dana-Farber Cancer Institute, Boston, USA; New York Stem Cell Foundation, Robertson Investigator, New York, USA.; Grzelak M; Omniscope Inc., Palo Alto, USA.; Borcherding N; Omniscope Inc., Palo Alto, USA.; Heyn H; Omniscope Inc., Palo Alto, USA.; Vivancos A; Vall d'Hebron Institute of Oncology (VHIO), Cancer Genomics Group, Barcelona, Spain.; Parker JS; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA.; Villagrasa P; Reveal Genomics, Barcelona, Spain.; Perou CM; Department of Genetics, University of North Carolina, Chapel Hill, USA; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA.; Prat A; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain; Reveal Genomics, Barcelona, Spain; Institute of Oncology (IOB)-Hospital Quirónsalud, Barcelona, Spain.; Brasó-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain; Reveal Genomics, Barcelona, Spain. Electronic address: FBRASO@recerca.clinic.cat.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Tomás Pascual; Aranzazu Fernandez-Martinez; Maki Tanioka; M. Vittoria Dieci; Sonia Pernas; Joaquin Gavila; Valentina Guarneri; Javier Cortes; Patricia Villagrasa; Núria Chic; Maria Vidal; Barbara Adamo; Montserrat Muñoz; Gaia Griguolo; Antonio Llombart; Pierfranco Conte; Mafalda Oliveira; Benedetta Conte; Laia Paré; Patricia Galvan; Lisa A. Carey; Charles M. Perou; Aleix Prat

CLINICAL CANCER RESEARCH
r-FISABIO. Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
instname

Prat A; Guarneri V; Paré L; Griguolo G; Pascual T; Dieci MV; Chic N; González-Farré B; Frassoldati A; Sanfeliu E; Cejalvo JM; Muñoz M; Bisagni G; Brasó-Maristany F; Urso L; Vidal M; Brandes AA; Adamo B; Musolino A; Miglietta F; Conte B; Oliveira M; Saura C; Pernas S; Alarcón J; Llombart-Cussac A; Cortés J; Manso L; López R; Ciruelos E; Schettini F; Villagrasa P; Carey LA; Perou CM; Piacentini F; D'Amico R; Tagliafico E; Parker JS; Conte P

LANCET ONCOLOGY
r-FISABIO. Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
The Lancet. Oncology

Velasco R; Unit of Neuro-Oncology, Hospital Universitari de Bellvitge. Catalan Institute of Oncology-L'Hospitalet, Carrer de La Feixa Llarga, s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain. rvelascof@bellvitgehospital.cat.; Institute of Neurosciences and Department of Cell Biology, Physiology and Immunology, Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas, Universitat Autònoma de Barcelona, Bellaterra, Spain. rvelascof@bellvitgehospital.cat.; Argyriou AA; Neurology Department, Agios Andreas General Hospital of Patras, Patras, Greece.; Marco C; Unit of Neuro-Oncology, Hospital Universitari de Bellvitge. Catalan Institute of Oncology-L'Hospitalet, Carrer de La Feixa Llarga, s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.; Mariotto S; Neurology Unit, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.; Stradella A; Department of Medical Oncology, Breast Cancer Unit, ICO L'Hospitalet (IDIBELL), Barcelona, Spain.; Hernández J; Institute of Neurosciences and Department of Cell Biology, Physiology and Immunology, Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas, Universitat Autònoma de Barcelona, Bellaterra, Spain.; Pernas S; Department of Medical Oncology, Breast Cancer Unit, ICO L'Hospitalet (IDIBELL), Barcelona, Spain.; Ferrari S; Neurology Unit, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.; Bruna J; Unit of Neuro-Oncology, Hospital Universitari de Bellvitge. Catalan Institute of Oncology-L'Hospitalet, Carrer de La Feixa Llarga, s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.; Institute of Neurosciences and Department of Cell Biology, Physiology and Immunology, Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas, Universitat Autònoma de Barcelona, Bellaterra, Spain.

Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1459 (Electronic) Linking ISSN: 03405354 NLM ISO Abbreviation: J Neurol Subsets: MEDLINE

Ignatiadis, M; Saloustros, ES; Joaquim, A; Grillet, F; Marcou, Y; Pernas, S; Neven, P; Berron, SDB; Ponce-Lorenzo, JJ; Menke-van, der Houven Van Oordt CW

JOURNAL OF CLINICAL ONCOLOGY. 43(16_SUPPL)

Nuciforo, P; Pascual, T; Cortés, J; Llombart-Cussac, A; Fasani, R; Paré, L; Oliveira, M; Galvan, P; Martínez, N; Bermejo, B; Vidal, M; Pernas, S; López, R; Muñoz, M; Garau, I; Manso, L; Alarcón, J; Martínez, E; Rodrik-Outmezguine, V; Brase, J C; Villagrasa, P; Prat, A; Holgado, E

Annals of Oncology. Jan 01, 2018 29(1):170-177

Salinas-Huertas S; Department of Rehabilitation, Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, Barcelona, Spain.; Luzardo-González A; Department of Rehabilitation, Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, Barcelona, Spain.; Vázquez-Gallego S; Department of Rehabilitation, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain.; Pernas S; Department of Oncology, Multidisciplinary Breast Cancer Unit, Institut Català d'Oncología, Barcelona, Spain.; Falo C; Department of Oncology, Multidisciplinary Breast Cancer Unit, Institut Català d'Oncología, Barcelona, Spain.; Pla MJ; Department of Gynecology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, Barcelona, Spain.; Gil-Gil M; Department of Oncology, Multidisciplinary Breast Cancer Unit, Institut Català d'Oncología, Barcelona, Spain.; Beranuy-Rodriguez M; Department of Rehabilitation, Hospital de la Santa Creu i Sant Pau, Universitat de Barcelona, Barcelona, Spain.; Pérez-Montero H; Department of Oncologic Radiotherapy, Multidisciplinary Breast Cancer Unit, Institut Català d'Oncología, Barcelona, Spain.; Gomila-Sancho M; Department of Rehabilitation, Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, Barcelona, Spain.; Manent-Molina N; Department of Rehabilitation, Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, Barcelona, Spain.; Arencibia-Domínguez A; Department of Rehabilitation, Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, Barcelona, Spain.; Gonzalez-Pineda B; Department of Rehabilitation, Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, Barcelona, Spain.; Tormo-Collado F; Department of Rehabilitation, Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, Barcelona, Spain.; Ortí-Asencio M; Department of Rehabilitation, Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, Barcelona, Spain.; Terra J; Department of Rehabilitation, Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, Barcelona, Spain.; Martinez-Perez E; Department of Oncologic Radiotherapy, Multidisciplinary Breast Cancer Unit, Institut Català d'Oncología, Barcelona, Spain.; Mestre-Jane A; Department of Rehabilitation, Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, Barcelona, Spain.; Campos-Varela I; Department of Rehabilitation, Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, Barcelona, Spain.; Jaraba-Armas M; Department of Rehabilitation, Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, Barcelona, Spain.; Benítez-Segura A; Department of Nuclear Medicine, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Idibell, Barcelona, Spain.; Campos-Delgado M; Department of Gynecology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, Barcelona, Spain.; Fernández-Montolí ME; Department of Gynecology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, Barcelona, Spain.; Valverde-Alcántara Y; Department of Cancer Prevencion and Control, Institut Català d'Oncología, Barcelona, Spain.; Rodríguez A; Breast Functional Unit, Institut Català d'Oncología, Barcelona, Spain.; Campos G; Breast Functional Unit, Institut Català d'Oncología, Barcelona, Spain.; Guma A; Department of Radiology, Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, Barcelona, Spain.; Ponce-Sebastià J; Department of Gynecology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, Barcelona, Spain.; Planas-Balagué R; Department of Rehabilitation, Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, Barcelona, Spain.; Catasús-Clavé M; Department of Rehabilitation, Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, Barcelona, Spain.; García-Tejedor A; Department of Gynecology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, Barcelona, Spain.

Publisher: SAGE Publications Country of Publication: United States NLM ID: 8801277 Publication Model: Print Cited Medium: Internet ISSN: 1558-1551 (Electronic) Linking ISSN: 08886008 NLM ISO Abbreviation: Breast Dis Subsets: MEDLINE

Fabregat-Franco C; Medical Oncology Department, Catalan Institute of Oncology, Duran i Reynals Hospital, Av Gran Via de L'Hospitalet, 199-203 L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain. cfabregat@iconcologia.net.; Stradella A; Medical Oncology Department, Catalan Institute of Oncology, Duran i Reynals Hospital, Av Gran Via de L'Hospitalet, 199-203 L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain.; Navarro V; Clinical Research Unit, Catalan Institute of Oncology, Av Gran Via de L'Hospitalet, L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain.; Linares J; Medical Oncology Department, Catalan Institute of Oncology, Duran i Reynals Hospital, Av Gran Via de L'Hospitalet, 199-203 L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain.; Galdeano M; Radiotherapy Oncology Department, Catalan Institute of Oncology, Av Gran Via de L'Hospitalet, L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain.; Recalde S; Medical Oncology Department, Catalan Institute of Oncology, Duran i Reynals Hospital, Av Gran Via de L'Hospitalet, 199-203 L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain.; Velasco R; Neuro-Oncology Unit, Catalan Institute of Oncology, Av Gran Via de L'Hospitalet, L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain.; Simo M; Neuro-Oncology Unit, Catalan Institute of Oncology, Av Gran Via de L'Hospitalet, L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain.; Fernadez A; Medical Oncology Department, Catalan Institute of Oncology, Duran i Reynals Hospital, Av Gran Via de L'Hospitalet, 199-203 L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain.; Venthecourt AC; Medical Oncology Department, Catalan Institute of Oncology, Duran i Reynals Hospital, Av Gran Via de L'Hospitalet, 199-203 L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain.; Falo C; Medical Oncology Department, Catalan Institute of Oncology, Duran i Reynals Hospital, Av Gran Via de L'Hospitalet, 199-203 L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain.; Vazquez S; Medical Oncology Department, Catalan Institute of Oncology, Duran i Reynals Hospital, Av Gran Via de L'Hospitalet, 199-203 L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain.; Bergamino M; Medical Oncology Department, Catalan Institute of Oncology, Duran i Reynals Hospital, Av Gran Via de L'Hospitalet, 199-203 L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain.; Villanueva R; Medical Oncology Department, Catalan Institute of Oncology, Duran i Reynals Hospital, Av Gran Via de L'Hospitalet, 199-203 L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain.; Pernas S; Medical Oncology Department, Catalan Institute of Oncology, Duran i Reynals Hospital, Av Gran Via de L'Hospitalet, 199-203 L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain.; Gil-Gil MJ; Medical Oncology Department, Catalan Institute of Oncology, Duran i Reynals Hospital, Av Gran Via de L'Hospitalet, 199-203 L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain.

Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

Griguolo G; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy.; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Serna G; Molecular oncology group, Vall d´Hebron Institute of Oncology, Barcelona, Spain.; Pascual T; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Fasani R; Molecular oncology group, Vall d´Hebron Institute of Oncology, Barcelona, Spain.; Guardia X; Molecular oncology group, Vall d´Hebron Institute of Oncology, Barcelona, Spain.; Chic N; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain.; Paré L; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Pernas S; Institut Catala d'Oncologia-H.U.Bellvitge-IDIBELL, Hospitalet, Barcelona, Spain.; Muñoz M; Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain.; Oliveira M; Medical Oncology Department, Vall d'Hebrón University Hospital, Barcelona, Spain.; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Vidal M; Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain.; Llombart-Cussac A; Hospital Universitario Arnau de Vilanova de Valencia, Valencia, Spain.; Cortés J; IOB Institute of Oncology, Quironsalud Group, Madrid & Barcelona, Spain.; Galván P; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Bermejo B; Hospital Clínico Universitario de Valencia/INCLIVA/CIBERONC, Valencia, Spain.; Martínez N; Hospital Universitario Ramón y Cajal, Madrid, Spain.; López R; Hospital Clínico Universitario de Santiago, IDIS, CIBERONC, Santiago de Compostela, Spain.; Morales S; Hospital Universitario Arnau de Vilanova de Lleida, Lleida, Spain.; Garau I; Hospital Son Llàtzer, Palma de Mallorca, Spain.; Manso L; Hospital Universitario 12 de Octubre, Madrid, Spain.; Alarcón J; Hospital Universitario Son Espases, Palma de Mallorca, Spain.; Martínez E; Consorcio Hospitalario Provincial de Castellón, Castellón de la Plana, Spain.; Villagrasa P; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Prat A; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. alprat@clinic.cat.; Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain. alprat@clinic.cat.; SOLTI Breast Cancer Research Group, Barcelona, Spain. alprat@clinic.cat.; Nuciforo P; Molecular oncology group, Vall d´Hebron Institute of Oncology, Barcelona, Spain. pnuciforo@vhio.net.; SOLTI Breast Cancer Research Group, Barcelona, Spain. pnuciforo@vhio.net.

Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Casas, A; Ciruelos, E; Oliveira, M; Saura, C; Bellet, M; Pernas, S; Gavila, J; Munoz, M; Vidal, M; Farre, BG; Cejalvo, JM; Lopez, R; Vivancos, A; Scaltriti, M; Bofill, JS; Blancas, I; Alba, E; Boni, V; De la Cruz, S; Galve, E; Perello, A; Margeli, M; Canes, J; Celiz, P; Masanas, H; Olmos, R; Fonts, M; Fernandez-Pascual, P; Villagrasa, P; Prat, A

Cancer Research
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
instname

Villacampa G; SOLTI Breast Cancer Research Group, Barcelona; Oncology Data Science, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Tung NM; Beth Israel, Boston, USA.; Pernas S; Medical Oncology Department, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona.; Paré L; Reveal Genomics, Barcelona.; Bueno-Muiño C; Medical Oncology Department, Hospital Infanta Cristina (Parla), Fundación de Investigación Biomédica del H.U. Puerta de Hierro, Majadahonda, Madrid.; Echavarría I; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CiberOnc, Madrid.; López-Tarruella S; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CiberOnc, Madrid.; Roche-Molina M; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CiberOnc, Madrid.; Del Monte-Millán M; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CiberOnc, Madrid.; Marín-Aguilera M; Reveal Genomics, Barcelona.; Brasó-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.; Waks AG; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston, USA.; Pascual T; SOLTI Breast Cancer Research Group, Barcelona; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.; Martínez-Sáez O; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.; Vivancos A; Cancer Genomics Group, VHIO, Barcelona, Spain.; Conte PF; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova; Istituto Oncologico Veneto, IRCCS, Padova, Italy.; Guarneri V; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova; Istituto Oncologico Veneto, IRCCS, Padova, Italy.; Vittoria Dieci M; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova; Istituto Oncologico Veneto, IRCCS, Padova, Italy.; Griguolo G; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova; Istituto Oncologico Veneto, IRCCS, Padova, Italy.; Cortés J; International Breast Cancer Center, Pangaea Oncology, Quirónsalud Group, Barcelona.; Llombart-Cussac A; Arnau de Vilanova Hospital, Universidad Católica de Valencia, Valencia, Spain.; Muñoz M; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.; Vidal M; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.; Adamo B; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.; Wolff AC; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore.; DeMichele A; Department of Oncology, University of Pennsylvania, Philadelphia.; Villagrasa P; Reveal Genomics, Barcelona.; Parker JS; Lineberger Comprehensive Cancer Center, Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill.; Perou CM; Lineberger Comprehensive Cancer Center, Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill.; Fernandez-Martinez A; Lineberger Comprehensive Cancer Center, Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill.; Carey LA; Lineberger Comprehensive Cancer Center, Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill.; Mittendorf EA; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston, USA; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, USA.; Martín M; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CiberOnc, Madrid.; Prat A; Reveal Genomics, Barcelona; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain; Institute of Oncology (IOB)-Quirón, Barcelona, Spain. Electronic address: alprat@clinic.cat.; Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Institute of Oncology (IOB)-Quirón, Barcelona, Spain. Electronic address: sara_tolaney@dfci.harvard.edu.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Mateo, F; Arenas, EJ; Aguilar, H; Serra-Musach, J; de Garibay, G Ruiz; Boni, J; Maicas, M; Du, S; Iorio, F; Herranz-Ors, C; Islam, A; Prado, X; Llorente, A; Petit, A; Vidal, A; Català, I; Soler, T; Venturas, G; Rojo-Sebastian, A; Serra, H; Cuadras, D; Blanco, I; Lozano, J; Canals, F; Sieuwerts, AM; de Weerd, V; Look, MP; Puertas, S; García, N; Perkins, AS; Bonifaci, N; Skowron, M; Gómez-Baldó, L; Hernández, V; Martínez-Aranda, A; Martínez-Iniesta, M; Serrat, X; Cerón, J; Brunet, J; Barretina, MP; Gil, M; Falo, C; Fernández, A; Morilla, I; Pernas, S; Plà, MJ; Andreu, X; Seguí, MA; Ballester, R; Castellà, E; Nellist, M; Morales, S; Valls, J; Velasco, A; Matias-Guiu, X; Figueras, A; Sánchez-Mut, JV; Sánchez-Céspedes, M; Cordero, A; Gómez-Miragaya, J; Palomero, L; Gómez, A; Gajewski, TF; Cohen, EEW; Jesiotr, M; Bodnar, L; Quintela-Fandino, M; López-Bigas, N; Valdés-Mas, R; Puente, XS; Viñals, F; Casanovas, O; Graupera, M; Hernández-Losa, J; Ramón y Cajal, S; García-Alonso, L; Saez-Rodriguez, J; Esteller, M; Sierra, A; Martín-Martín, N; Matheu, A; Carracedo, A; González-Suárez, E; Nanjundan, M; Cortés, J; Lázaro, C; Odero, MD; Martens, JWM; Moreno-Bueno, G; Barcellos-Hoff, MH; Villanueva, A; Gomis, RR; Pujana, MA

Oncogene
Recercat. Dipósit de la Recerca de Catalunya
instname
RUO. Repositorio Institucional de la Universidad de Oviedo
Universidad de Oviedo (UNIOVI)
RUO: Repositorio Institucional de la Universidad de Oviedo
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
RISalud-ANDALUCIA. Repositorio Institucional de Salud de Andalucía
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
RIUVic. Repositorio Institucional de la Universidad de Vic
RiUVic. Repositori institucional de la UVic-UCC
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Repisalud
Instituto de Salud Carlos III (ISCIII)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Oncogene, vol 36, iss 19
Oncogene : including Oncogene reviews 36(19), 2737-2749 (2017). doi:10.1038/onc.2016.427

Oliveira M; SOLTI Cancer Research Group, Barcelona; Medical Oncology Department, Vall d'Hebron University Hospital, and Breast Cancer Group, Vall D'Hebron Institute of Oncology (VHIO), Barcelona. Electronic address: https://twitter.com/MOliveira_MD.; Falato C; SOLTI Cancer Research Group, Barcelona; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden.; Cejalvo JM; SOLTI Cancer Research Group, Barcelona; Medical Oncology Department, Hospital Clínico Universitario de Valencia, Valencia.; Vila MM; SOLTI Cancer Research Group, Barcelona; Medical Oncology Department, ICO - Institut Català d'Oncologia Badalona (Hospital Universitario Germans Trias i Pujol), Badalona.; Tolosa P; SOLTI Cancer Research Group, Barcelona; Medical Oncology Department, Hospital 12 de Octubre, Madrid.; Salvador-Bofill FJ; SOLTI Cancer Research Group, Barcelona; Medical Oncology Department, Hospital Universitario Virgen del Rocio, Sevilla.; Cruz J; SOLTI Cancer Research Group, Barcelona; Medical Oncology Department, Hospital Universitario de Canarias, Santa Cruz de Tenerife.; Arumi M; SOLTI Cancer Research Group, Barcelona; Medical Oncology Department, Vall d'Hebron University Hospital, and Breast Cancer Group, Vall D'Hebron Institute of Oncology (VHIO), Barcelona.; Luna AM; SOLTI Cancer Research Group, Barcelona; Medical Oncology Department; Centro Integral Oncológico Clara Campal HM (CIOCC), Madrid.; Guerra JA; SOLTI Cancer Research Group, Barcelona; Medical Oncology Department, Hospital de Fuenlabrada, Fuenlabrada.; Vidal M; SOLTI Cancer Research Group, Barcelona; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clinic de Barcelona, Barcelona.; Martínez-Sáez O; SOLTI Cancer Research Group, Barcelona; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clinic de Barcelona, Barcelona.; Paré L; SOLTI Cancer Research Group, Barcelona.; González-Farré B; SOLTI Cancer Research Group, Barcelona; Pathology Department, Hospital Clinic of Barcelona, Barcelona.; Sanfeliu E; SOLTI Cancer Research Group, Barcelona; Pathology Department, Hospital Clinic of Barcelona, Barcelona.; Ciruelos E; SOLTI Cancer Research Group, Barcelona; Medical Oncology Department, Hospital 12 de Octubre, Madrid.; Espinosa-Bravo M; SOLTI Cancer Research Group, Barcelona; Breast Cancer Surgical Unit, Vall d'Hebron University Hospital, Barcelona.; Pernas S; SOLTI Cancer Research Group, Barcelona; Medical Oncology Department, Catalan Institute of Oncology - ICO, Breast Cancer Group; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona.; Izarzugaza Y; SOLTI Cancer Research Group, Barcelona; Medical Oncology Department, Fundación Jimenez Díaz, Madrid, Spain.; Esker S; Research and Development, Daiichi Sankyo, Inc, Basking Ridge, USA.; Fan PD; Research and Development, Daiichi Sankyo, Inc, Basking Ridge, USA.; Parul P; Research and Development, Daiichi Sankyo, Inc, Basking Ridge, USA.; Santhanagopal A; Research and Development, Daiichi Sankyo, Inc, Basking Ridge, USA.; Sellami D; Research and Development, Daiichi Sankyo, Inc, Basking Ridge, USA.; Villacampa G; SOLTI Cancer Research Group, Barcelona.; Ferrero-Cafiero JM; SOLTI Cancer Research Group, Barcelona.; Pascual T; SOLTI Cancer Research Group, Barcelona; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clinic de Barcelona, Barcelona.; Prat A; SOLTI Cancer Research Group, Barcelona; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clinic de Barcelona, Barcelona. Electronic address: ALPRAT@clinic.cat.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Buckland G; Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Travier N; Unit Breast Cancer Screening Unit, Cancer Prevention and Control Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Arribas L; Clinical Nutrition Unit, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.; Del Barco S; Department of Medical Oncology-ICO, Hospital Universitari de Girona Dr Josep Trueta, Girona, Spain.; Pernas S; Breast Cancer Unit, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.; Zamora E; Department of Breast Cancer Oncology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Bellet M; Department of Breast Cancer Oncology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Cirauqui B; Department of Medical Oncology-ICO, Hospital Germans Trias i Pujol, Badalona, Spain.; Margelí M; Department of Medical Oncology-ICO, Hospital Germans Trias i Pujol, Badalona, Spain.; Muñoz M; Translational Genomics and Targeted Therapeutics, Institut d'Investigacions Biomèdiques Pi i Sunyer IDIBAPS, Barcelona, Spain.; Tusquets I; Department of Medical Oncology, Hospital del Mar, Barcelona, Spain.; Arcusa A; Department of Medical Oncology, Consorci Sanitari de Terrassa, Terrassa, Spain.; Javierre C; Department of Physiological Sciences II, School of Medicine, University of Barcelona, Barcelona, Spain.; Moreno F; Breast Cancer Unit, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.; Valverde Y; Breast Cancer Unit, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.; Jansen E; Centre for Health Protection, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.; Chajès V; Nutrition and Metabolism Department, International Agency for Research on Cancer, Lyon, France.; Castro C; Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Agudo A; Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.

Publisher: Wiley on behalf of The British Dietetic Association Ltd., [c1988- Country of Publication: England NLM ID: 8904840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-277X (Electronic) Linking ISSN: 09523871 NLM ISO Abbreviation: J Hum Nutr Diet Subsets: MEDLINE

Buckland, G; Travier, N; Arribas, L; del Barco, S; Pernas, S; Zamora, E; Bellet, M; Jansen, E; etal

Ayala de la Peña F; Department of Hematology and Medical Oncology, Hospital G. Universitario Morales Meseguer, Avda. Marqués de los Vélez, s/n, 30001, Murcia, Spain. frayala@um.es.; Andrés R; Division of Medical Oncology, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.; Garcia-Sáenz JA; Department of Medical Oncology, Hospital Clínico Universitario San Carlos, Madrid, Spain.; Manso L; Department of Medical Oncology, University Hospital, 12 de Octubre, Madrid, Spain.; Margelí M; Department of Medical Oncology, Breast Cancer Unit, B-ARGO Group, Institut Català d'Oncologia, Badalona, Spain.; Dalmau E; Department of Oncology, Parc Taulí Sabadell, Hospital Universitari, Barcelona, Spain.; Pernas S; Department of Medical Oncology, Breast Cancer Unit, Institut Català d'Oncologia, Barcelona, Spain.; Prat A; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain.; Servitja S; Department of Medical Oncology, Hospital del Mar, Barcelona, Spain.; Ciruelos E; Department of Medical Oncology, Breast Cancer Unit, University Hospital, 12 de Octubre, Madrid, Spain.; HM Hospitales, Madrid, Spain.

Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE